From: Optimal treatment of opioid induced constipation in daily clinical practice – an observational study
Opioid maintenance typea | N= | Note on laxation pattern N (%)b,c | Morphine dose (MEDD)d median (IQR) | ConstipationeN (%) | MEDDd,f median (IQR) | Opioid Induced Constipationg,h N (%) | MEDDi median (IQR) | Admission for OICj N (%)k | MEDDl median (IQR) |
---|---|---|---|---|---|---|---|---|---|
No maintenance opioid | 94 | 77 (82) | 0 (0) | 12 (13) | 0 (0) | 1 (1) | 0 (0) | 1 (1) | 0 |
Buprenorfine | 16 | 16 (100) | 105 (31–180) | 5 (31) | 24 (17–98) | 3 (19) | 30 (17–120)m | 2 (13) | 54 (17–90)o |
Fentanyl | 110 | 86 (78) | 89 (60–150) | 25 (23) | 89 (60–180) | 18 (16) | 89 (60–180) | 11 (10) | 180 (60–180) |
Methadon | 3 | 2 (67) | 60 (60–240)m | 2 (67) | 120 (60–240)m | 1 (33) | 240 (0) | 0 (0) | n.a. |
Morphine | 5 | 3 (60) | 60 (40–96) | 3 (60) | 60 (40–96)m | 2 (40) | 68 (40–96)m | 3 (60) | 60 (40–80)o |
Oxycodon | 81 | 64 (79) | 40 (40–80) | 19 (23) | 40 (40–80) | 12 (15) | 40 (40–80) | 5 (6) | 60 (40–140) |
Tramadol | 14 | 7 (50) | 30 (20–40) | 1 (7) | 20 (0) | 1 (7) | 20 (0) | 0 (0) | n.a. |
Other | 4 | 2 (50) | 7 (5–10)m | 1 (25) | n.a.n | 1 (25) | n.a.n | 0 (0) | n.a. |
Total | 327 | 257 (79) | 60 (40–120) | 68 (21) | 60 (40–120) | 39 (12) | 60 (40–120) | 22 (7) | 70 (40–180) |